Evan Y. Yu, MD | Authors

Targeted Therapy in the Treatment of Castration-Resistant Prostate Cancer

July 15, 2013

In this review, we focus on the testosterone/androgen receptor pathway that is being targeted with potent new agents; we also discuss other important alternative biologic pathways that have given rise to new therapeutics that may attenuate prostate cancer growth, survival, and propagation.